Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 203 participants.
Also called NCT04707508
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 203 participants
- Sponsor
- Nantou Christian Hospital
- Registry
-
NCT04707508
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT04707508. Non-randomized; no masking; primary purpose treatment. Start 2017-12-01 (actual); primary completion 2019-01-23 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Valsartan 80 mg and metformin
- Intervention (Drug)
- Metformin
- Lead sponsor
- Nantou Christian Hospital
Record details
- Record id
cardio:ct-nct04707508- Content hash
07683645508708555d4e2205b65c11fa15fb727ee3a5a31b2d334eb9a602284c